These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 10073684

  • 1. Cell surface markers and circulating cytokines in graft versus host disease.
    Chang DM, Wang CJ, Kuo SY, Lai JH.
    Immunol Invest; 1999 Jan; 28(1):77-86. PubMed ID: 10073684
    [Abstract] [Full Text] [Related]

  • 2. Serum cytokine levels after HLA-identical bone marrow transplantation.
    Liem LM, van Houwelingen HC, Goulmy E.
    Transplantation; 1998 Oct 15; 66(7):863-71. PubMed ID: 9798695
    [Abstract] [Full Text] [Related]

  • 3. The identification and characteristics of IL-22-producing T cells in acute graft-versus-host disease following allogeneic bone marrow transplantation.
    Zhao K, Zhao D, Huang D, Song X, Chen C, Pan B, Wu Q, Cao J, Yao Y, Zeng L, Xu K.
    Immunobiology; 2013 Dec 15; 218(12):1505-13. PubMed ID: 23816304
    [Abstract] [Full Text] [Related]

  • 4. Serum concentration of the soluble interleukin-2 receptor for monitoring acute graft-versus-host disease.
    Miyamoto T, Akashi K, Hayashi S, Gondo H, Murakawa M, Tanimoto K, Harada M, Niho Y.
    Bone Marrow Transplant; 1996 Feb 15; 17(2):185-90. PubMed ID: 8640164
    [Abstract] [Full Text] [Related]

  • 5. Clinical relevance of serum soluble interleukin-2 receptor levels in acute and chronic graft-versus-host disease.
    Kobayashi S, Imamura M, Hashino S, Tanaka J, Asaka M.
    Leuk Lymphoma; 1997 Dec 15; 28(1-2):159-69. PubMed ID: 9498715
    [Abstract] [Full Text] [Related]

  • 6. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
    Shaiegan M, Iravani M, Babaee GR, Ghavamzadeh A.
    Transpl Immunol; 2006 Jan 15; 15(3):223-7. PubMed ID: 16431290
    [Abstract] [Full Text] [Related]

  • 7. Transplantation-related complications predicted by cytokine gene expression in the mixed lymphocyte culture in allogeneic bone marrow transplants.
    Tanaka J, Imamura M, Kasai M, Sakurada K.
    Leuk Lymphoma; 1995 Sep 15; 19(1-2):27-32. PubMed ID: 8574169
    [Abstract] [Full Text] [Related]

  • 8. Monitoring soluble interleukin-2 receptor levels in related and unrelated donor allogenic bone marrow transplantation.
    Foley R, Couban S, Walker I, Greene K, Chen CS, Messner H, Gauldie J.
    Bone Marrow Transplant; 1998 Apr 15; 21(8):769-73. PubMed ID: 9603399
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of graft-versus-host disease by interleukin-2 treatment is associated with altered cytokine production by expanded graft-versus-host-reactive CD4+ helper cells.
    Wang MG, Szebeni J, Pearson DA, Szot GL, Sykes M.
    Transplantation; 1995 Sep 15; 60(5):481-90. PubMed ID: 7676498
    [Abstract] [Full Text] [Related]

  • 10. Idiopathic pneumonia syndrome in mice after allogeneic bone marrow transplantation.
    Shankar G, Bryson JS, Jennings CD, Morris PE, Cohen DA.
    Am J Respir Cell Mol Biol; 1998 Feb 15; 18(2):235-42. PubMed ID: 9476911
    [Abstract] [Full Text] [Related]

  • 11. Soluble interleukin-2 receptor levels in cytomegalovirus disease and graft versus host disease after T-lymphocyte depleted bone marrow transplantation for hematological neoplasias.
    Engelhard D, Nagler A, Singer R, Barak V.
    Leuk Lymphoma; 1994 Jan 15; 12(3-4):273-80. PubMed ID: 8167558
    [Abstract] [Full Text] [Related]

  • 12. Cytokine dysregulation as a mechanism of graft versus host disease.
    Ferrara JL.
    Curr Opin Immunol; 1993 Oct 15; 5(5):794-9. PubMed ID: 8240742
    [Abstract] [Full Text] [Related]

  • 13. Serum levels of soluble interleukin-2 receptor after bone marrow transplantation: a true marker of acute graft-versus-host disease.
    Kami M, Matsumura T, Tanaka Y, Mikami Y, Miyakoshi S, Ueyama J, Morinaga S, Mori S, Machida U, Kanda Y, Chiba S, Sakamaki H, Hirai H, Muto Y.
    Leuk Lymphoma; 2000 Aug 15; 38(5-6):533-40. PubMed ID: 10953974
    [Abstract] [Full Text] [Related]

  • 14. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA.
    Dan Med Bull; 2002 May 15; 49(2):89-108. PubMed ID: 12064093
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.
    Szebeni J, Wang MG, Pearson DA, Szot GL, Sykes M.
    Transplantation; 1994 Dec 27; 58(12):1385-93. PubMed ID: 7809932
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.
    Biol Blood Marrow Transplant; 1997 Apr 27; 3(1):11-7. PubMed ID: 9209736
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
    Dander E, Balduzzi A, Zappa G, Lucchini G, Perseghin P, Andrè V, Todisco E, Rahal D, Migliavacca M, Longoni D, Solinas G, Villa A, Berti E, Mina PD, Parma M, Allavena P, Biagi E, Rovelli A, Biondi A, D'Amico G.
    Transplantation; 2009 Dec 15; 88(11):1261-72. PubMed ID: 19996925
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.